RhumbLine Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.91M Sell
355,461
-5,625
-2% -$134K 0.01% 1178
2025
Q4
$9.64M Sell
361,086
-30,463
-8% -$728K 0.01% 1074
2025
Q3
$8.36M Buy
391,549
+24,463
+7% +$579K 0.01% 1165
2025
Q2
$7.92M Buy
367,086
+14,370
+4% +$267K 0.01% 1169
2025
Q1
$5.86M Buy
352,716
+177,188
+101% +$3.22M 0.01% 1273
2024
Q4
$3.22M Sell
175,528
-2,613
-1% -$42.2K ﹤0.01% 1637
2024
Q3
$2.74M Sell
178,141
-8,359
-4% -$139K ﹤0.01% 1724
2024
Q2
$3.03M Buy
186,500
+2,121
+1% +$34.2K ﹤0.01% 1668
2024
Q1
$3.41M Buy
184,379
+1,095
+0.6% +$27.1K ﹤0.01% 1618
2023
Q4
$5.74M Sell
183,284
-1,116
-0.6% -$26.7K 0.01% 1332
2023
Q3
$3.84M Buy
184,400
+3,624
+2% +$98.4K ﹤0.01% 1499
2023
Q2
$4.33M Buy
180,776
+6,977
+4% +$155K ﹤0.01% 1464
2023
Q1
$3.27M Buy
173,799
+917
+0.5% +$17.5K ﹤0.01% 1561
2022
Q4
$2.75M Buy
172,882
+5,322
+3% +$83.2K ﹤0.01% 1618
2022
Q3
$2.74M Buy
167,560
+16,545
+11% +$268K ﹤0.01% 1599
2022
Q2
$2.13M Buy
151,015
+17,571
+13% +$328K ﹤0.01% 1734
2022
Q1
$3.23M Buy
133,444
+5,011
+4% +$121K ﹤0.01% 1571
2021
Q4
$3M Sell
128,433
-1,740
-1% -$35K ﹤0.01% 1663
2021
Q3
$2.16M Buy
130,173
+1,651
+1% +$31.8K ﹤0.01% 1872
2021
Q2
$3.13M Buy
128,522
+12,840
+11% +$290K ﹤0.01% 1700
2021
Q1
$2.98M Sell
115,682
-9,114
-7% -$401K ﹤0.01% 1710
2020
Q4
$6.67M Buy
124,796
+100
+0.1% +$4.96K 0.01% 1186
2020
Q3
$5.14M Sell
124,696
-7,515
-6% -$325K 0.01% 1152
2020
Q2
$6.41M Sell
132,211
-30,324
-19% -$1.46M 0.01% 1051
2020
Q1
$6.87M Buy
162,535
+1,758
+1% +$72.4K 0.01% 846
2019
Q4
$6.88M Buy
160,777
+13,709
+9% +$596K 0.01% 1068
2019
Q3
$5.29M Sell
147,068
-3,462
-2% -$105K 0.01% 1158
2019
Q2
$4.02M Buy
150,530
+462
+0.3% +$11.8K 0.01% 1321
2019
Q1
$4.03M Buy
150,068
+17,252
+13% +$403K 0.01% 1300
2018
Q4
$2.15M Buy
132,816
+44,513
+50% +$864K ﹤0.01% 1600
2018
Q3
$1.83M Sell
88,303
-6,015
-6% -$94.6K ﹤0.01% 1707
2018
Q2
$1.44M Sell
94,318
-7,910
-8% -$141K ﹤0.01% 1851
2018
Q1
$2.3M Sell
102,228
-6,132
-6% -$170K ﹤0.01% 1519
2017
Q4
$3.26M Sell
108,360
-2,734
-2% -$87.4K 0.01% 1329
2017
Q3
$4.18M Sell
111,094
-4,682
-4% -$152K 0.01% 1146
2017
Q2
$3.23M Sell
115,776
-1,573
-1% -$46.9K 0.01% 1271
2017
Q1
$4.03M Sell
117,349
-340
-0.3% -$12K 0.01% 1140
2016
Q4
$3.39M Buy
117,689
+9,006
+8% +$238K 0.01% 1141
2016
Q3
$3.46M Buy
108,683
+9,653
+10% +$327K 0.01% 1091
2016
Q2
$3.21M Buy
99,030
+18,190
+23% +$609K 0.01% 1060
2016
Q1
$2.26M Buy
80,840
+6,150
+8% +$134K 0.01% 1290
2015
Q4
$2.66M Buy
74,690
+1,715
+2% +$60.4K 0.01% 1170
2015
Q3
$2.41M Buy
72,975
+1,522
+2% +$63.3K 0.01% 1214
2015
Q2
$2.99M Sell
71,453
-2,800
-4% -$108K 0.01% 1145
2015
Q1
$2.42M Buy
74,253
+11,685
+19% +$402K 0.01% 1272
2014
Q4
$1.99M Sell
62,568
-595
-0.9% -$16.9K 0.01% 1350
2014
Q3
$1.56M Sell
63,163
-4,090
-6% -$95.7K ﹤0.01% 1490
2014
Q2
$1.52M Buy
67,253
+4,996
+8% +$104K ﹤0.01% 1555
2014
Q1
$1.51M Sell
62,257
-3,240
-5% -$82K ﹤0.01% 1533
2013
Q4
$1.64M Buy
65,497
+3,270
+5% +$77.1K ﹤0.01% 1492
2013
Q3
$1.71M Buy
62,227
+8,827
+17% +$185K 0.01% 1446
2013
Q2
$969K Buy
+53,400
New +$736K ﹤0.01% 1786

Other funds holding ACAD